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Comparative Evaluation of Nanofibrous Scaffolding
for Bone Regeneration in Critical-Size Calvarial Defects
Kyung Mi Woo, D.D.S., Ph.D.,1 Victor J. Chen, Ph.D.,2 Hong-Moon Jung, B.S.,1
Tae-Il Kim, D.D.S., Ph.D.,3 Hong-In Shin, D.D.S., Ph.D.,4 Jeong-Hwa Baek, D.D.S., Ph.D.,1
Hyun-Mo Ryoo, D.D.S., Ph.D.,1 and Peter X. Ma, Ph.D.2,5,6
In a previous study we found that nanofibrous poly(l-lactic acid) (PLLA) scaffolds mimicking collagen fibers in
size were superior to solid-walled scaffolds in promoting osteoblast differentiation and bone formation in vitro.
In this study we used an in vivo model to confirm the biological properties of nanofibrous PLLA scaffolds and to
evaluate how effectively they support bone regeneration against solid-walled scaffolds. The scaffolds were
implanted in critical-size defects made on rat calvarial bones. Compared with solid-walled scaffolds, nanofi-
brous scaffolds supported substantially more new bone tissue formation, which was confirmed by micro-
computed tomography measurement and von Kossa staining. Goldner’s trichrome staining showed abundant
collagen deposition in nanofibrous scaffolds but not in the control solid-walled scaffolds. The cells in these
scaffolds were immuno-stained strongly for Runx2 and bone sialoprotein (BSP). In contrast, solid-walled scaf-
folds implanted in the defects were stained weakly with trichrome, Runx2, and BSP. These in vivo results
demonstrate that nanofibrous architecture enhances osteoblast differentiation and bone formation.
Introduction
Scaffolds play a critical role in tissue engineering,which aims to regenerate missing tissues or organs.1
Because they serve as artificial temporary extracellular ma-
trix (ECM) until cells replace them with newly synthesized
natural ECM, scaffolds should reproduce the structural and
biochemical functions of natural ECM. The performance of a
scaffold is affected by several factors, including the chemical
nature of the scaffolding material and the physical structures
at various size scales, which are dependent on the method of
fabrication. It is often beneficial for the scaffolds to mimic
certain advantageous characteristics of the natural ECM, or
developmental or wound healing programs.2
Because natural ECM is mainly composed of fibrous col-
lagen, our laboratory and others have proposed to develop
nanofibrous materials as advanced scaffolds for tissue engi-
neering.3–5 Various techniques, including electrospinning,6–8
self-assembly,9,10 and phase separation,3,4,11–13 have recently
been explored to fabricate nanofibrous materials. Our labo-
ratory has developed a novel phase separation method to
generate synthetic nanofibrous scaffolds with a morphology
similar to that of natural collagen fibers, unique in that it
allows for the design of pore structure.2 While there has been
active development of the nanofibrous scaffolds, there are
limited comparative reports providing evidence that nano-
fibrous scaffolds are superior to conventional solid-walled
scaffolds.14–16 Previously, we reported that, compared with
solid-walled scaffolds, nanofibrous scaffolds improved ad-
sorption of proteins, including fibronectin and vitronectin,
both of which may mediate cell interactions with the scaf-
fold.15 The nanofibrous and solid-walled scaffolds were
made from the same biodegradable polymer, poly(l-lactic
acid) (PLLA), and have similar macropore structure (inter-
connected spherical pores formed by paraffin sphere poro-
gen, pore diameter¼ 250–420 mm).15 Both the nanofibrous
(average fiber diameter was between 100 and 200 nm) and
solid-walled scaffolds had similar porosities of 96% (calcu-
lated from scaffold mass, dimensions, and crystallinity).15
The only difference was in the wall architecture of the mac-
ropores. Special processing conditions were employed to
form the macropores of the nanofibrous scaffolds, as previ-
ously published.4,11,17 Using an in vitro culture system, we
found that synthetic nanofibers (mimicking the geometrical
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features of collagen fibers) advantageously support osteo-
blastic differentiation and biomineralization.16,18 In the
present study, we evaluated the 3D nanofibrous scaffolds on
in vivo bone formation in comparison to 3D solid-walled
scaffolds. Critical-size defects were made at the center of
calvarial bone in rats. Scaffolds without cells were implanted
in the defects. Bone formation in the defects was evaluated
using micro-computed tomography (micro-CT) and von
Kossa staining. Formation of collagen fibers was examined
by Goldner’s trichrome staining. Osteoblastic differentiation
of cells in scaffolds was examined through immunostaining
for Runx2 and bone sialoprotein (BSP). The results suggest
that the nanofibrous morphology of the scaffolds promotes
osteoblast differentiation and bone formation in vivo.
Materials and Methods
Preparation of nanofibrous
and solid-walled PLLA scaffolds
The scaffold preparation has been reported in detail pre-
viously.11,15 Briefly, for nanofibrous PLLA scaffolds, a 12.5%
(w=v) PLLA solution in a 1:1 (v=v) mixture of dioxane and
pyridine, was prepared by stirring at 608C for 1–2 h until a
homogeneous solution was obtained. Paraffin spheres (di-
ameter, 250–420 mm; 0.40 0.01 g) were added to Teflon
molds, and heat-treated at 378C for 45 min. After the molds
were cooled to room temperature, prepared polymer solu-
tion (0.32 mL) was added dropwise onto each paraffin sphere
assembly, and the assembly was treated in a vacuum oven
(250 mmHg, *378C) to remove air trapped inside the par-
affin sphere assemblies. Vacuum treatment was done as
quickly as possible to avoid further bonding of the paraf-
fin spheres. The polymer solution was induced to phase-
separate at 708C overnight. The molds were then immersed
into cold hexane for 2 days (188C) to extract the solvent.
The materials were removed from the molds and punched
into disks 8 mm in diameter and 1.5 mm in thickness. The
specimens were then placed into hexane to extract the re-
maining solvent and to leach the paraffin. Specimens were
kept in hexane at room temperature for 2 days, and the
hexane was changed three times every day. Hexane was then
replaced with cyclohexane, and the polymer matrices were
removed from the cyclohexane and frozen at 708C for at
least 6 h. The frozen matrices were then lyophilized at 708C,
placed under vacuum (<30 mmHg) for 7 days, placed in an
ice=salt bath (5 to 108C, <30 mmHg) for two additional
days, and dried at room temperature under the same pres-
sure for the final 2 days.
For PLLA solid-walled scaffolds, a 12.5% (w=v) PLLA
solution was prepared by stirring in dioxane at 608C for 1–
2 h until a homogeneous solution was obtained. The paraffin
sphere mold preparation and the polymer casting proce-
dures were performed in the same manner as for the nano-
fibrous scaffolds. After polymer solution casting, the
polymer=paraffin composites were dried under low vacuum
(&340 mmHg) overnight, and under high vacuum
(<30 mmHg) for four additional days. Samples were re-
moved from the molds and punched into disks 8 mm in di-
ameter and 1.5 mm in thickness. Paraffin leaching with
hexane, solvent exchange with cyclohexane, and lyophilizing
procedures were performed in the same manner as for the
nanofibrous scaffolds. The nanofibrous and solid-walled
scaffolds were sterilized with ethylene oxide following the
manufacturer’s procedure (H.W. Anderson Products, Chapel
Hill, NC).
Animals and surgical procedures
All procedures were approved by Institute of Laboratory
Animal Resources at Seoul National University (authoriza-
tion number SNU-050608-3). Sprague–Dawley rats (250–
300 g) were used in this study. Sample size was determined
as n¼ 4, based on the pilot result of micro-CT [a¼ 0.05,
b¼ 0.20, and s¼ 1.1; effect size (expected mean difference
in the newly formed bone volume)¼ 2.2]. A critical-size rat
calvarial bone defect was created as previously described.19
The animals were anesthetized with a subcutaneous injection
of a mixture of ketamine and xylazine (40 and 9 mg=kg, re-
spectively). The scalp covering the calvarial vault was shaved
and scrubbed with betadine solution and infiltrated with a
local anesthetic agent of 2% lidocaine with 1:100,000 epi-
nephrine. An incision was made along the midline. Full-
thickness skin and the periosteum were raised to expose
the calvarial bone surface. Careful drilling with an 8-mm-
diameter trephine bur was done around the sagittal suture,
and a standardized, round, segmental defect was made.
During drilling, the area was irrigated with saline solution
and the underlying dura mater was maintained intact. A
nanofibrous or a solid-walled scaffold, without cells, was
placed in the defect. The periosteum (pericranium) and skin
were closed in layers with absorbable 5–0 chromic catgut
(WRHI, Namyangju, Korea) and nonabsorbable 4–0 black silk
(Ethicon, Edinburgh, United Kingdom) sutures, respectively.
Micro-CT
Rats were sacrificed 4 or 8 weeks after scaffold implanta-
tion. Calvarial bone was excised, trimmed, and fixed in 4%
paraformaldehyde for 24 h at 48C. The specimens were ex-
amined using a micro-CT machine (Skyscan 1072; Skyscan,
Aartselaar, Belgium). Specimens were placed on a cylindrical
sample holder with the coronal aspect of calvarial bone in a
horizontal position to ensure parallel scanning conditions.
The resolution was set at 19.5 mm, averaging by two frames
with median filtration. Rotation step of 0.98 and rotation
angle of 1808 were set to take approximately 500 slices of the
scan. Files were reconstructed using a modified Feldkamp
algorithm, which was created using microtomographic
analysis software (TomoNT; Skyscan). After the 3D visual-
izing process, bone volumes were measured in the region of
interest from four animals in each group. In addition, micro-
CT scan was also performed in animals of which defects
were not treated with any scaffolds, serving as the negative
control. The bone volume was obtained by subtracting the
value of negative control from the value of the experimental
specimen. The data are presented as average standard er-
ror of means (SEM). Student’s t-test was done using Micro-
soft Excel software to compare the differences between two
groups.
Histology
After micro-CT measurement, the specimen was divided
into two parts along the sagittal suture for the calcified and
decalcified section preparations. The specimens for the cal-
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cified section were placed in 70% ethanol, dehydrated in
graded concentrations of alcohol, and embedded in methy-
methacrylate resin (Technovit 9100; Kulzer, Wehrheim,
Germany). After the resin blocks were trimmed, 5-mm-thick
sections were prepared with a microtome (Leica RM2156;
Leica, Wetzlar, Germany) equipped with a tungsten carbide
knife. The sections were stained with von Kossa and Gold-
ner’s trichrome. The samples for the decalcified section were
decalcified in 10% EDTA for 10 days at room temperature,
dehydrated through ascending graded alcohol, embedded in
paraffin, sectioned at 5mm, and stained with H&E.
Immunostaining
Immunostaining was performed for Runx2 and BSP. The
sections from four animals in each group were depar-
affinized, washed in PBS, and heated in a microwave for
2 min. The sections were incubated in a 3% H2O2 solution to
quench any endogenous peroxidases in the section. The sec-
tions were blocked with 1% antigoat serum in PBS for 30 min
at room temperature, and incubated in primary anti-Runx2
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or anti-
BSP antibody (developed by Solursh and Franzen, obtained
from the Developmental Studies Hybridoma Bank under the
auspices of the NICHD and maintained at The University of
Iowa in the Department of Biological Sciences) at 48C over-
night. Incubation in the isotype-control antibodies (antirabbit
IgG for Runx2, antimouse IgG2 for BSP; Santa Cruz Biotech-
nology) was also performed and served as negative controls
of immunostaining. After washing with PBS, the sections
were incubated in horseradish peroxidase–conjugated sec-
ondary antibodies for 30 min at room temperature, followed
FIG. 1. Bone formation in rat
critical-size calvarial defects.
(A) Reconstructed micro-CT
images of the scaffolds im-
planted for 8 weeks (upper,
solid-walled scaffolds; lower,
nanofibrous scaffolds). The
dotted circles indicate the
original defect. Bar length:
1 mm. (B) Bone volumes of the
constructs after subtracting the
value of the negative
control (not treated with any
scaffold). Data are presented
as average SEM. (n¼ 4).
*Statistically significant
(Student’s t-test, p< 0.05).
Color images available online
at www.liebertonline.com=ten.
FIG. 2. Von Kossa staining
views of scaffolds implanted
in calvarial defects for 8
weeks. (A) Solid-walled scaf-
folds; (B) nanofibrous scaf-
folds. Original magnification,
20. Bar length: 1 mm. Re-
presentative images are pre-
sented. Color images available
online at www.liebertonline
.com=ten.
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by treatment with diaminobenzidene solution (DAB; Dako
Cytomation, Carpinteria, CA).
Results
Bone formation in the calvarial defects
Bone formation was evident in the nanofibrous scaffolds
implanted in critical-size calvarial bone defects. This obser-
vation was confirmed by micro-CT measurements and von
Kossa staining (Figs. 1 and 2). New bone formation in the
bony defects measured by micro-CT 8 weeks after implan-
tation was about 2.1-fold higher in the nanofibrous scaffolds
than in the solid-walled scaffolds (Fig. 1), obtained by sub-
tracting the bone volume of negative controls from that of
the experimental constructs (Fig. 1B). At an earlier time point
of 4 weeks after implantation, the difference between the two
scaffold groups in bone volume was not statistically signifi-
cant; only one out of four nanofibrous scaffolds contained
noticeable amounts of newly formed bone tissue at that time
(data not shown). However, at 8 weeks after implantation,
significantly more bone formation in the nanofibrous scaf-
folds than in the solid-walled scaffolds was consistently
FIG. 3. Histological images
of H&E-stained solid-walled
scaffolds (A, C, E) and nano-
fibrous scaffolds (B, D, F)
implanted in calvarial defects
for 8 weeks. Arrowheads
mark the site of original de-
fects (A, B). Peripheral parts
(C, D) and central parts (E, F)
of the defects are shown.
Original magnification: (A, B),
20; (C, D), 100; (E, F), 200.
Bar length: (A, B), 1 mm;
(C, D), 100 mm; (E, F), 100 mm.
Representative images are
presented. Color images
available online at www
.liebertonline.com=ten.
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confirmed by all measurements: reconstructed micro-CTs
and histological analyses by von Kossa and H&E stains (Figs.
1A, 2, and 3). In solid-walled scaffolds new bone formation
only occurred in the periphery of the disk-shaped scaffolds.
In contrast, in the nanofibrous scaffolds new bone formation
was observed both in the center and in the periphery. In the
central area of nanofibrous scaffolds, the new bone nodules
were more frequently observed on the dura mater side than
on the pericranium side, and the new bone tissue was rich in
cells (appearing as immature bone) and formed in the shape
of globules in the pores of the scaffolds. There was not a
significant difference in the amount and pattern of bone
formation in the peripheral areas between the two types of
scaffolds; new bone tissues were formed in linear apposition
to adjacent bone, appearing more mature with a low cell
density.
FIG. 4. Histological images
by Goldner’s Trichrome
staining of solid-walled (A, C,
E) and nanofibrous scaffolds
(B, D, F) implanted in calvar-
ial defects for 8 weeks. Col-
lagens are stained in green
color. Overall views (A, B),
peripheral parts (C, D), and
central parts (E, F) of the
defects are shown. Original
magnification: (A, B), 20;
(C, D), 100; (E, F), 200. Bar
length: (A, B), 1 mm; (C, D),
100mm; (E, F), 100 mm.
Representative images are
presented. Color images
available online at www
.liebertonline.com=ten.
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Osteoblast phenotypes
The collagen formation within the implanted scaffolds
was examined using Goldner’s trichrome staining. As shown
in Figure 4, green-stained dense collagen matrix was ob-
served in nanofibrous scaffolds, especially inside the pores of
the scaffolds, where von Kossa staining was also positive.
The solid-walled scaffolds were low in collagen (green) al-
though cells (stained in red) were not rare. The cells in the
scaffolds were examined for osteoblastic differentiation
through immunostaining for the Runx2 (early osteogenic
marker) and BSP (late osteogenic marker). The cells in na-
nofibrous scaffolds strongly stained (dark brown) for Runx2
and BSP, especially in cells around the ossicles (Figs. 5 and
6). The solid-walled scaffolds, however, had very weak
stains. These results suggest that the cells recruited to na-
nofibrous scaffolds differentiated to osteoblasts responsible
for collagen synthesis and mineralized bone formation.
Discussion
This in vivo study was to determine whether the nanofi-
brous architecture of 3D porous scaffolds is suitable for use
in bone regeneration. We compared the bone regenerative
properties of nanofibrous 3D scaffolds with those of solid-
walled 3D scaffolds implanted in a rat critical-size calvarial
bone defect. Both types of scaffolds were made from the
same polymer (PLLA) and had the same macropore struc-
ture (interconnected spherical pores). Their porosities and
pore sizes were also similar. The difference was in the wall
architecture of the macropores, i.e., either nanofibrous or
solid-walled (no fibrous feature). In this study, the scaffolds
without cells were implanted in the defects to highlight the
effect of scaffolding structure on bone regeneration by host
cells. The results demonstrate that the nanofibrous structure
of scaffolds enhances osteoblast differentiation, collagen
matrix deposition, and mineralized bone formation, as con-
firmed by immunostaining for Runx2 and BSP, Goldner’s
trichrome staining for collagen, and von Kossa staining and
micro-CT measurement for mineral contents. The cells that
differentiated to bone-forming osteoblasts were most likely
derived from tissues surrounding the defects: the dura ma-
ter, the pericranium, and the bone tissues. These three tissue
types have been reported to contain cells responsible for
bone formation in similar defects.20 The most notable dif-
ference between the nanofibrous and the solid-walled scaf-
folds was in the location where bone formation occurred.
The central part of nanofibrous scaffolds, but not that of
solid-walled scaffolds, contained numerous globular ossicles.
The cells responsible for bone formation in the central part
should have come from dura mater or pericranium, which
need a cue to differentiate into functional osteoblasts.
We previously found that synthetic nanofibers enhanced
osteoblast differentiation and mineralization in vitro.16 We
showed in this in vivo study that the cells in nanofibrous
scaffolds were strongly immunostained for Runx2 and BSP,
and that bone formation in the nanofibrous scaffolds was at
a much higher level than that in the solid-walled scaffolds.
These results indicate that nanofibrous scaffolds provide
a better environment for osteoblastic differentiation in vivo
as well.
FIG. 5. Immunostaining for
Runx2 protein in solid-
walled scaffolds (A) and
nanofibrous scaffolds (B)
implanted in calvarial defects
for 4 weeks. After im-
munostaining (dark brown),






available online at www
.liebertonline.com=ten.
FIG. 6. Immunostaining for
BSP in solid-walled scaffolds
(A) and nanofibrous scaffolds
(B) implanted in calvarial
defects for 4 weeks. After
immunostaining (dark
brown), the sections were
counterstained with hema-
toxylin. Original magnifica-
tion, 200. Bar length, 50mm.
Representative images are
presented. Color images
available online at www
.liebertonline.com=ten.
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The nanofibrous scaffolds were developed to mimic the
fibrous morphology of type I collagen, a major component of
bone ECM that is known to affect osteoblast behavior. Cells
grown on collagen exhibit an earlier and enhanced osteoblast
phenotype.21 Collagen also positively mediates biominer-
alization.22 It was recently reported that mineral was de-
posited by Runx2-expressing fibroblasts seeded on collagen,
but not on smooth polymer scaffolds.23 Previously, we
showed that synthetic nanofibers enhanced the adsorption of
adhesion proteins (likely due partially to the larger surface
area24 of and partially to their preferential interaction15 with
the nanofibrous scaffold) from the serum in culture medium
and enhanced the expression of a few integrins, which may
have contributed to the cell signaling.15,16 We also found that
the osteoblastic differentiation of cells on nanofibrous scaf-
folds was enhanced by the nanofibrous geometry (compared
to solid-walled scaffolds) rather than a collagen-mimicking
chemistry (gelatin surface coating), and the enhanced BSP
gene expression was associated with the RhoA-ROCK sig-
naling pathway.18
We would like to mention the possible contributions of
local mass transport conditions. Although the overall pore
sizes and porosities were essentially the same for the two
types of scaffolds as discussed earlier, the local mass trans-
port conditions for cells in contact with the nanofibrous and
solid-walled pores might likely be different. The nanofibrous
pore walls might allow for improved nutrient=oxygen sup-
ply to and metabolic waste removal from the attached cells.
The in vitro faster degradation of nanofibrous scaffolds does
not seem fast enough to result in significant scaffold mac-
ropore change within the experimental time frame.24 How-
ever, the in vivo degradation properties of the two types of
PLLA scaffolds have not been carefully compared to rule out
their possible effect.
In any case, this study confirmed that synthetic polymers
with a nanofibrous morphology could promote osteoblast
differentiation and bone formation in an in vivo model. Ta-
ken together, the synthetic nanofibrous PLLA scaffolds, by
mimicking the geometrical features of collagen fibers, en-
hance their capacity to facilitate both in vitro and in vivo
osteoblast differentiation and bone formation.
Conclusion
Nanofibrous scaffolds, mimicking the fibrous morphology
of type I collagen, supported bone formation when the scaf-
folds were implanted in a rat critical-size calvarial defect,
while solid-walled scaffolds resulted in very limited amounts
of bone formation in only the peripheral regions. More col-
lagen was synthesized in nanofibrous scaffolds than in solid-
walled scaffolds. Cells in nanofibrous scaffolds expressed
higher levels of Runx2 and BSP, especially near the newly
formed ossicles. These findings suggest that nanofibrous
scaffolds promote osteoblast differentiation and bone forma-
tion, and are excellent scaffolds for bone tissue engineering.
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